MK-2420 SAD Study

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511297-73-00

Acronym

MK-2420-001

Enrollment

96

Registered

2024-04-25

Start date

2024-05-03

Completion date

2025-02-24

Last updated

2024-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC

Lead SponsorINDUSTRY

Eligibility

Sex/Gender

Male

Age

18 Years to 64 Years

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026